Find Faculty
Fred Lublin, MD
img_Fred Lublin
PROFESSOR | Neurology
212-241-6854
Are you a patient?
View my
Provider Profile
Specialties
Neurology
Multiple Sclerosis
Clinical trials in MS and other demyelination disorders
Neuroimmunology
Basic and translational neuroimmunology

MD, Thomas Jefferson University

Internship, Internal Medicine, Albert Einstein College of Medicine-Yeshiva University

Residency, Neurology, Weill Medical College of Cornell University

Certifications

American Board of Psychiatry and Neurology

2019

Award for Recognition of Leadership and Dedication in Applying Medical Education to Improve Care of Patients with Multiple Sclerosis

AcademicCME, Advanced Curriculum for Multiple Sclerosis

2019

June Halpern Lifetime Achievement Award

Consortium of Multiple Sclerosis Centers

2019

Presidential Lecture

Consortium of Multiple Sclerosis Centers

2017

Clifford Goldsmith Award

Icahn School of Medicine at Mount Sinai

2017

Honorary Member of the French Society of Neurology

Societe Francaise de Neurologie

2013

Award of Appreciation for Outstanding Academic Teaching

Icahn School of Medicine at Mount Sinai

2001

Attending of the Year Award

Mount Sinai Medical Center Neurology Residents

2000

Chairman, Research Programs Advisory Committee

National Multiple Sclerosis Society

1999

McEwan Visiting Professorship & Lecture in Neurology

University of Toronto

1999

Hope Award

National Multiple Sclerosis Society, Delaware Valley Chapter

1996

Milestone Award

National Multiple Sclerosis Society, Delaware Valley Chapter

326
Publications

Selected Publications

Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis. Kaarina Kowalec, Arvid Harder, Casandra Dolovich, Kathryn C. Fitzgerald, Amber Salter, Yi Lu, Charles N. Bernstein, James M. Bolton, Gary Cutter, John D. Fisk, Joel Gelernter, Lesley A. Graff, Sara Hägg, Carol A. Hitchon, Daniel F. Levey, Fred D. Lublin, Kyla A. McKay, Scott Patten, Amit Patki, Murray B. Stein, Hemant K. Tiwari, Jerry S. Wolinsky, Ruth A. Marrie. Annals of Clinical and Translational Neurology

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset. Marcus W. Koch, Ester Moral, Luis Brieva, Jop Mostert, Eva M.M. Strijbis, Jacynthe Comtois, Pavle Repovic, James D. Bowen, Jerry S. Wolinsky, Fred D. Lublin, Gary Cutter. Multiple Sclerosis Journal

Worsening MS—A reappraisal of how we characterize the MS disease course. Fred D. Lublin. Multiple Sclerosis Journal

View All Publications

Mount Sinai Doctors Floor 1st Floor

5 E 98th St

New York, NY 10029

212-241-6854

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Lublin during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Biogen MA Inc
  • Immunic
  • InnoCare Pharma
  • Viatris
  • Novartis Pharmaceutical Corporation
  • Baim Institute for Clinical Research
  • Franklin Casualty
  • Gibson Dunn
  • Kilcoyne & Nesbitt
  • LAPIX Therapeutics, Inc.
  • Greebenrg Traurig Law Firm
  • Kaufman Borgeest & Ryan Law Firm
  • Clene
  • Horizon Therapeutics, LLC
  • Sanofi Genzyme
  • Cooper Levenson
  • Setpoint Medical
  • Cognito Therapeutics
  • Neuralight, Inc.
  • Sandoz-Warner, Inc.
  • Bristol-Myers Squibb
  • ImmPACT Bio
  • Abata therapeutics
  • Furman Kornfeld & Brennan
  • Avotres Inc.
  • Entelexo
  • Wilmer Hale Law Firm
  • PLESNER ADVOKATPARTNERSELSKAB
  • EMD Serono, Inc
  • Biohaven Pharmaceuticals
  • Sudo Biosciences

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Avotres Inc.
  • Entelexo
  • LAPIX Therapeutics, Inc.
  • Neuralight, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.